摘要
肿瘤微环境构成了促进肿瘤的生长和恶化的条件,不仅对癌症本身产生作用,还影响其与免疫,内皮细胞和神经细胞的相互作用。细胞外ATP及其受体最近在肿瘤学领域获得越来越多的关。ATP在肿瘤环境中的蓄积通过自发释放,肿瘤坏死或化疗对癌细胞产生营养活性,调节肿瘤之间以及周围组织之间的相互作用。因此, ATP控P2X受体成为在肿瘤的发生发展、侵袭、进展和相关症状中的核心因子。事实上, P2X受体不仅在肿瘤细胞上,而且在免疫浸润和附近的神经元被表达并发挥功能。在这次审查中,我们总结了P2X受体在肿瘤细胞分化、生物能、血管生成、转移和相关的疼痛中的最新研究进展结果,概括了受体激动剂和拮抗剂的潜在抗肿瘤活性。
关键词: 癌症,细胞外ATP , P2X2 , P2X3 , P2X4 , P2X5 , P2X7 ,疼痛。
Current Medicinal Chemistry
Title:Emerging Roles of P2X Receptors in Cancer
Volume: 22 Issue: 7
Author(s): Elena Adinolfi, Marina Capece, Francesca Amoroso, Elena De Marchi and Alessia Franceschini
Affiliation:
关键词: 癌症,细胞外ATP , P2X2 , P2X3 , P2X4 , P2X5 , P2X7 ,疼痛。
摘要: Tumor microenvironment composition strongly conditions cancer growth and progression, acting not only at cancer itself but also modifying its interactions with immune, endothelial and nervous cells. Extracellular ATP and its receptors recently gained increasing attention in the oncological field. ATP accumulates in cancer milieu through spontaneous release, tumor necrosis or chemotherapy exerting a trophic activity on cancer cells, modulating the cross talk among tumor, and surrounding tissues. Accordingly, ATP gated P2X receptors emerged as central players in tumor development, invasion, progression and related symptoms. Indeed, P2X receptors are expressed and are functional not only on tumor cells but also in immune-infiltrate and nearby neurons. In this review, we summarize recent findings on P2X receptors role in tumor cell differentiation, bioenergetics, angiogenesis, metastasis and associated pain, giving an outline of the potential anti-neoplastic activity of receptor agonists and antagonists.
Export Options
About this article
Cite this article as:
Elena Adinolfi, Marina Capece, Francesca Amoroso, Elena De Marchi and Alessia Franceschini , Emerging Roles of P2X Receptors in Cancer, Current Medicinal Chemistry 2015; 22 (7) . https://dx.doi.org/10.2174/0929867321666141012172913
DOI https://dx.doi.org/10.2174/0929867321666141012172913 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases
Current Medicinal Chemistry Oncomirs: From Tumor Biology to Molecularly Targeted Anticancer Strategies
Mini-Reviews in Medicinal Chemistry Natural Antibodies: Protecting Role of IgM in Glioblastoma and Brain Tumours
Current Pharmaceutical Design CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts
Current Radiopharmaceuticals The Impact of Gynecological Cancer on Reproductive Issues and Pregnancy:Psychological Implications
Current Women`s Health Reviews Molecular Components of Wnt/β-catenin Pathway As Therapeutic Targets For Upper Gastrointestinal Cancers
Clinical Cancer Drugs Cancer Metastasis: Characterization and Identification of the Behavior of Metastatic Tumor Cells and the Cell Adhesion Molecules, including Carbohydrates
Current Drug Targets - Cardiovascular & Hematological Disorders The Endocannabinoid System in the Cancer Therapy: An Overview
Current Medicinal Chemistry MicroRNAs: Association with Radioresistant and Potential Uses of Natural Remedies as Green Gene Therapeutic Approaches
Current Gene Therapy Thyroid Hormones Crosstalk with Growth Factors: Old Facts and New Hypotheses
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Progesterone Receptor Membrane Component 1 and its Accomplice: Emerging Therapeutic Targets in Lung Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Isoform-Selective PI3K Inhibitors for Various Diseases
Current Topics in Medicinal Chemistry Progresses in TCM Metal-Based Antitumour Agents
Anti-Cancer Agents in Medicinal Chemistry Disulfiram's Anticancer Activity: Evidence and Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Reactive Oxygen Species, Cancer and Anti-Cancer Therapies
Current Chemical Biology Biology of PPARγ in Cancer: A Critical Review on Existing Lacunae
Current Molecular Medicine The Role of PEDF in Tumor Growth and Metastasis
Current Molecular Medicine Immune Responses to Adeno-Associated Virus Vectors
Current Gene Therapy